According to the Zhitong Finance App, Meinong Biotech (301156.SZ) released its report for the third quarter of 2026. In the first three quarters, the company achieved revenue of 540 million yuan, an increase of 38.38% over the previous year. Net profit attributable to shareholders of listed companies was 27.919 million yuan, a year-on-year decrease of 31.77%. Net profit attributable to shareholders of listed companies after deducting non-recurring profit and loss was 265.981 million yuan, a year-on-year decrease of 30.87%.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.